Per-Jostein Samuelsen
Overview
Explore the profile of Per-Jostein Samuelsen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
77
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hallberg A, Aakjaer M, Aaltonen K, Andersen M, Pedersen E, Hajiebrahimi M, et al.
Arch Public Health
. 2025 Feb;
83(1):46.
PMID: 39980066
Background: During the initial phase of the COVID-19 pandemic, there was an intensive debate on which strategies would be most effective to minimize the negative societal impact of the pandemic....
2.
Samuelsen P, Wettermark B, Nyberg F, Hajiebrahimi M
Basic Clin Pharmacol Toxicol
. 2025 Jan;
136(2):e14119.
PMID: 39757371
The COVID-19 pandemic may have increased anticoagulant initiation due to the thrombogenic nature of the disease or decreased due to the societal impact of the pandemic. We aimed to study...
3.
Vo C, Wilsgaard T, Samuelsen P, Mathiesen E, Sommerseth H, Eggen A, et al.
BMJ Open
. 2024 Dec;
14(12):e089819.
PMID: 39725421
Objectives: There is limited evidence regarding the impact of lipid-lowering drugs (LLDs) on the socioeconomic gradient in a longitudinal perspective. The study investigates the longitudinal socioeconomic gradient in total cholesterol...
4.
Vambheim S, Hjellvik V, Odsbu I, Skurtveit S, Ekholdt C, Granan L, et al.
BMC Pharmacol Toxicol
. 2024 Oct;
25(1):81.
PMID: 39456108
Background: The utilization patterns of opioid analgesics and the proportion of long-term opioid use after surgery in Norway is largely unknown. Methods: This study aimed to estimate the proportion of...
5.
Vo C, Samuelsen P, Sommerseth H, Wisloff T, Wilsgaard T, Eggen A
BMC Public Health
. 2023 May;
23(1):994.
PMID: 37248482
Background: Differences in the sociodemographic characteristics of participants and non-participants in population-based studies may introduce bias and reduce the generalizability of research findings. This study aimed to compare the sociodemographic...
6.
Vo C, Samuelsen P, Sommerseth H, Wisloff T, Wilsgaard T, Eggen A
Scand J Public Health
. 2022 May;
51(7):1061-1068.
PMID: 35593433
Background: Self-reported data on educational level have been collected for decades in the Tromsø Study, but their validity has yet to be established. Aim: To investigate the completeness and correctness...
7.
Samuelsen P, Eggen A, Steigen T, Wilsgaard T, Kristensen A, Skogsholm A, et al.
PLoS One
. 2021 Mar;
16(3):e0247358.
PMID: 33661918
Introduction: Bleeding is a concern after percutaneous coronary intervention (PCI) and subsequent dual antiplatelet therapy (DAPT). We herein report the incidence and risk factors for major bleeding in the Norwegian...
8.
Samuelsen P, Slordal L, Mathisen U, Eggen A
BMC Pharmacol Toxicol
. 2017 Jun;
18(1):51.
PMID: 28655329
No abstract available.
9.
Samuelsen P, Nielsen C, Wilsgaard T, Stubhaug A, Svendsen K, Eggen A
BMC Pharmacol Toxicol
. 2017 Jun;
18(1):45.
PMID: 28599683
Background: Increased pain sensitivity is a putative risk factor for chronic pain and consequently for analgesic use. Conversely, analgesic use may be a cause of increased pain sensitivity, e.g., through...
10.
Samuelsen P, Svendsen K, Wilsgaard T, Stubhaug A, Nielsen C, Eggen A
Eur J Clin Pharmacol
. 2016 Apr;
72(8):977-85.
PMID: 27071993
Purpose: Analgesics are commonly used drugs. The long-term effectiveness is mostly unproven, while the risk of several serious adverse effects is well established. We aimed to estimate the prevalence and...